Cargando…

Allelic imbalance in CALR somatic mutagenesis

Detalles Bibliográficos
Autores principales:	Harutyunyan, A S, Jäger, R, Chen, D, Berg, T, Rumi, E, Gisslinger, B, Pietra, D, Gisslinger, H, Cazzola, M, Kralovics, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430307/ https://www.ncbi.nlm.nih.gov/pubmed/25567134 http://dx.doi.org/10.1038/leu.2015.3

Ejemplares similares

Thrombopoietin receptor is required for the oncogenic function of CALR mutants
por: Nivarthi, H, et al.
Publicado: (2016)

Common germline variation at the TERT locus contributes to familial clustering of myeloproliferative neoplasms
por: Jäger, Roland, et al.
Publicado: (2014)

PD‐L1 overexpression correlates with JAK2‐V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms
por: Milosevic Feenstra, Jelena D., et al.
Publicado: (2022)

Sequential evaluation of CALR mutant burden in patients with myeloproliferative neoplasms
por: Cavalloni, Chiara, et al.
Publicado: (2017)

Myelomonocytic Skewing In Vitro Discriminates Subgroups of Patients with Myelofibrosis with A Different Phenotype, A Different Mutational Profile and Different Prognosis
por: Geissler, Klaus, et al.
Publicado: (2020)

CALR mutations in myeloproliferative neoplasms: An unfolding story
por: Langabeer, Stephen E.
Publicado: (2020)

Complex Patterns of Chromosome 11 Aberrations in Myeloid Malignancies Target CBL, MLL, DDB1 and LMO2
por: Klampfl, Thorsten, et al.
Publicado: (2013)

Concurrent chronic myeloid leukemia and CALR-mutated myeloproliferative neoplasm
por: Langabeer, Stephen E.
Publicado: (2020)

Reply: Allelic imbalance of TGFBR1 is not a major contributor to the genetic predisposition to colorectal cancer
por: Valle, L, et al.
Publicado: (2011)

MARIMO cells harbor a CALR mutation but are not dependent on JAK2/STAT5 signaling
por: Kollmann, K, et al.
Publicado: (2015)

Leukocytosis and presence of CALR mutation is associated with non-hepatosplenic extramedullary hematopoiesis in primary myelofibrosis
por: Barraco, D, et al.
Publicado: (2016)

CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia
por: Cui, Yajuan, et al.
Publicado: (2014)

Myeloproliferative neoplasm-driving Calr frameshift promotes the development of pulmonary hypertension in mice
por: Minakawa, Keiji, et al.
Publicado: (2021)

Long non-coding RNAs display higher natural expression variation than protein-coding genes in healthy humans
por: Kornienko, Aleksandra E., et al.
Publicado: (2016)

Allelic imbalance of somatic mutations in cancer genomes and transcriptomes
por: Rhee, Je-Keun, et al.
Publicado: (2017)

Low-level somatic JAK2 V617F mutation in myelodysplastic/ myeloproliferative neoplasm with ring sideroblasts, and thrombocytosis with co-mutated SF3B1 and CALR
por: Ji, Young Sok, et al.
Publicado: (2022)

CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles
por: Zini, Roberta, et al.
Publicado: (2017)

Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms
por: Pietra, D, et al.
Publicado: (2016)

Allelic imbalance of the TGFβR1 is not a major contributor to the genetic predisposition to colorectal cancer
por: Abadie, C, et al.
Publicado: (2011)

Differences in Hematological and Clinical Features Between Essential Thrombocythemia Cases With JAK2- or CALR-Mutations
por: Kubuki, Yoko, et al.
Publicado: (2017)

Phenotypic correlations of CALR mutation variant allele frequency in patients with myelofibrosis
por: Guglielmelli, Paola, et al.
Publicado: (2023)

Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia
por: Barbui, T, et al.
Publicado: (2015)

Frequent CALR exon 9 alterations in JAK2 V617F-mutated essential thrombocythemia detected by high-resolution melting analysis
por: Lim, K-H, et al.
Publicado: (2015)

CALR mutation analysis is not indicated in patients with splanchnic vein thrombosis without evidence of a myeloproliferative neoplasm: a micro-review
por: Langabeer, Stephen E.
Publicado: (2016)

Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational status
por: Kubesova, B, et al.
Publicado: (2018)

In vivo tunable CRISPR mediates efficient somatic mutagenesis to generate tumor models
por: An, Xiaomeng, et al.
Publicado: (2018)

Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis
por: Guglielmelli, P, et al.
Publicado: (2015)

Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study
por: Tefferi, A, et al.
Publicado: (2013)

Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups
por: Gisslinger, Heinz, et al.
Publicado: (2020)

Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b
por: Kiladjian, Jean-Jacques, et al.
Publicado: (2022)

Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment
por: Gisslinger, Heinz, et al.
Publicado: (2023)

Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer
por: Staaf, Johan, et al.
Publicado: (2011)

Differential Dynamics of CALR Mutant Allele Burden in Myeloproliferative Neoplasms during Interferon Alfa Treatment
por: Kjær, Lasse, et al.
Publicado: (2016)

Mice with Calr mutations homologous to human CALR mutations only exhibit mild thrombocytosis
por: Shide, Kotaro, et al.
Publicado: (2019)

Allelic imbalance in human breast cancer
por: French, Juliet D., et al.
Publicado: (2017)

Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg-proline-interferon alpha-2b
por: Them, Nicole CC, et al.
Publicado: (2015)

Current and future treatment options for polycythemia vera
por: Griesshammer, Martin, et al.
Publicado: (2015)

Identification of somatic mutations in single cell DNA-seq using a spatial model of allelic imbalance
por: Luquette, Lovelace J., et al.
Publicado: (2019)

Somatic mutations are present in all members of the AKT family in endometrial carcinoma
por: Dutt, A, et al.
Publicado: (2009)

Targeted mutagenesis in rice using CRISPR-Cas system
por: Miao, Jin, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ntlmhpm6e4j1qpmjllcm5j9unv